phase readout
saveNCT06801834: Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC)
view source ↗
comments(0)
5-min edit window · permanent after that